{"schema_version":"1","generated_at":"2026-11-04T14:24:14.925Z","data_as_of":null,"url":"https://www.findmykol.com/kol/sargam-kapoor","json_url":"https://www.findmykol.com/kol/sargam-kapoor/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"sargam-kapoor","name":"Sargam Kapoor","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Cleveland","state":"OH","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1467893255","orcid":"0000-0003-0689-6197","openalex":"A5033698905"},"summary":"Sargam Kapoor is an Oncology physician. OpenAlex indexes 28 publications with 1,300 citations (h-index 8).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":28,"cited_by_count":1300,"h_index":8,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":1,"shown":1,"withheld":0,"rows":[{"payer":"Janssen Pharmaceuticals, Inc","program_year":2022,"amount_usd":16.09,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1467893255"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1467893255","source":"payments"},"prescribing":{"data_year":2024,"areas_total":1,"areas_shown":1,"areas":[{"area":"Blood & clotting","share_pct":100,"classes_total":2,"classes":[{"class":"Factor Xa inhibitor","setting":"prescribed","share_pct":93.1,"drugs":[{"name":"Eliquis","share_pct":87.8},{"name":"Xarelto","share_pct":12.2}],"max_beneficiaries":null},{"class":"Low Molecular Weight Heparin","setting":"prescribed","share_pct":6.9,"drugs":[{"name":"Enoxaparin Sodium","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":28,"shown":5,"withheld":23,"matched_by":"OpenAlex author record","recent":[{"title":"The complexity of \"provoked\" venous thromboembolism: one treatment plan does not fit all Commentary on the HI-PRO Trial.","year":2026,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2025018610","status":"verified"},{"title":"Impact of cytoreductive therapy in myeloproliferative neoplasm-associated splanchnic vein thrombosis","year":2026,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2026020925","status":"verified"},{"title":"Venous Thromboembolism in Transgender and Gender Diverse Individuals on Estrogen-Based Gender-Affirming Hormone Therapy","year":2026,"journal":"Journal of Clinical Medicine","source_url":"https://doi.org/10.3390/jcm15114166","status":"verified"},{"title":"Cytoreductive therapy reduces recurrent thrombosis in patients with myeloproliferative neoplasm-associated splanchnic vein thrombosis: A global abdominal/splanchnic thrombosis retrospective observational study (GASTRO-MPN) study of 757 patients","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-1026","status":"verified"},{"title":"Incidence of venous thromboembolism in transgender individuals on estrogen-based gender-affirming hormone therapy","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-313","status":"verified"}],"source":"works"},"contact":{"address_1":"11100 EUCLID AVENUE","address_2":"DEPARTMENT OF HEMATOLOGY-ONCOLOGY","city":"Cleveland","state":"OH","zip":"44106","phone":"216-762-0067","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1467893255","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":23}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2019-02-22","collected_at":"2026-11-03T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}